tiprankstipranks
Moderna Mulls COVID-19 Vaccine Price at $130
Market News

Moderna Mulls COVID-19 Vaccine Price at $130

Biotechnology company Moderna (NASDAQ:MRNA) is mulling a $130 price per COVID-19 dose in the U.S., according to Reuters.

The development comes as the process of procuring and distributing vaccines transitions from the government to commercial market dynamics. The previously declared COVID-19 pandemic emergency is about to expire in May.

The company had received nearly $1.7 billion in funding for the development of the vaccine and raked in nearly $18 billion from its sales last year. Nonetheless, contributions from COVID-19 vaccine sales to its top line have seen a decline.  

Overall, the Street has a $222.86 consensus price target on MRNA implying a hefty 44.2% potential upside in the stock. That’s after a 13.7% drop in the share price since the beginning of 2023.

Read full Disclosure

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles